Form D · Biotechnology
ICONIC THERAPEUTICS INC
South San Francisco, CA · CIK 0001226555
Offering snapshot reported Apr 26, 2019 · SEC filing
- Reported sold
- $13M Offering amount: $16.3M
- Investors reported
- 37 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 26, 2019 | Initial | $13,031,025 | No comparison | 37 | SEC filing |
| Jun 19, 2018 | Initial | $4,109,317 | No comparison | 36 | SEC filing |
| Nov 2, 2016 | Amendment | $48,561,000 | $10,561,000vs Jan 12, 2016 | 11 | SEC filing |
| Jan 12, 2016 | Initial | $38,000,000 | No comparison | 8 | SEC filing |
| Apr 23, 2014 | Initial | $13,258,905 | No comparison | 40 | SEC filing |
| Jan 16, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338229
Consists of cash in the agg amount of $2,809,459.40 and cancellation of principal and accrued interest due under outstanding promissory notes in the agg amount of $8,770,675.44 which was converted at a discounted price into $10,221,565.00 of shares.
Ser B Prime Pref Stk; also includes Ser A Prime Pref Stk issued in exchg for shares of Com Stk issued upon conversion of shares of prior Pref Stk in a mandatory conversion effective as of immediately prior to the sale of the Ser B Prime Pref Stk.
Source: Form D, filed Apr 26, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce Cohen | Director |
| Kirk Dornbush | Director |
| Todd Foley | Director |
| William Greene | Director, Executive |
| Julia Gregory | Director |
| Peter Hirth | Director |
| Johan Kordel | Director |
| Bruce Robertson | Director |
| Jon Soderstrom | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
442 Littlefield Avenue
South San Francisco, CA, 94080
South San Francisco, CA, 94080